dronabinol has been researched along with Myocardial Ischemia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Kędziora, P; Stasiak, A | 1 |
Bernatskaya, NA; Krylatov, AV; Maslov, LN; Mechoulam, R; Pertwee, RG; Ugdyzhekova, DS | 1 |
Krylatov, AV; Lasukova, OV; Lishmanov, IuB; Maslov, LN; Pertwee, R | 1 |
Garcia, EA; Grossman, AB; Hardie, DG; Hawley, SA; Hubina, E; Kirkham, TC; Kola, B; Korbonits, M; Mitchell, SE; Tucci, SA; Williams, LM | 1 |
4 other study(ies) available for dronabinol and Myocardial Ischemia
Article | Year |
---|---|
Myocardial ischaemia associated with tetrahydrocannabinol intake in a teenage boy: A case report.
Topics: Adolescent; Dronabinol; Humans; Male; Myocardial Ischemia | 2021 |
Activation of cannabinoid receptors decreases the area of ischemic myocardial necrosis.
Topics: Animals; Cardiotonic Agents; Dronabinol; Heart; Male; Myocardial Ischemia; Myocardium; Necrosis; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug | 2002 |
[Alterations of inotropic function of isolated heart and extent of injury of cardiomyocytes after cannabinoid receptor activation during ischemia and reperfusion].
Topics: Animals; Anti-Arrhythmia Agents; Cannabinoid Receptor Agonists; Cannabinoids; Dronabinol; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Receptors, Cannabinoid | 2003 |
Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Cannabinoids; Dimerization; Dronabinol; Ghrelin; Heart; Hypothalamus; Immunoblotting; Immunoprecipitation; In Situ Hybridization; Liver; Male; Metformin; Multienzyme Complexes; Muscle, Skeletal; Myocardial Ischemia; Peptide Hormones; PPAR gamma; Protein Serine-Threonine Kinases; Psychotropic Drugs; Rats; RNA, Messenger; Time Factors | 2005 |